Notice of Results

Eden Research plc

25 August 2026

 

Eden Research

("Eden" or the "Company")

Notice of Results

Investor Presentation

Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, announces that its preliminary results for the fifteen months ended 31 March 2026 will be released on Wednesday 26 August 2026.

Sean Smith, CEO, and Alex Abrey, CFO, will provide a live presentation in relation to the preliminary results via the Investor Meet Company platform on Wednesday, 26 August 2026 at 10:00 BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 25 August, 12:00 BST or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Eden Research plc via:https://www.investormeetcompany.com/eden-research-plc/register-investor

Investors who already follow Eden Research plc on the Investor Meet Company platform will automatically be invited.

For further information contact:

Eden Research plc			www.edenresearch.com
Sean Smith, Chief Executive Officer			Via Walbrook PR
Alex Abrey, Chief Financial Officer
Cavendish Capital Markets Limited (Nominated advisor and joint broker)				Tel: [phone]
Giles Balleny / Elysia Bough (Corporate Finance)
Harriet Ward (Corporate Broking) / Dale Bellis (Sales)
Oberon Capital (Joint Broker)			Tel: [phone]
Nick Lovering / Mike Seabrook / Adam Pollock
Walbrook PR (Media Relations & Investor Relations)		Tel: [phone] or [e-mail]
Paul McManus / Nick Rome / Anna Dunphy

Notes to Editors:

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has three products currently on the market:

Based on plant-derived active ingredients, Mevalone® is a foliar biofungicide which initially targets a key disease affecting grapes and other high-value fruit and vegetable crops.  It is a useful tool in crop defence programmes and is aligned with the requirements of integrated pest management programmes. It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally.

Cedroz™ is a bionematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally.  Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally.

Eden's seed treatment product (approval expected in 2026), Ecovelex was developed to safely tackle crop destruction caused by birds - a major cause of losses in maize and other crops. Ecovelex works by creating an unpleasant taste or odour that repels birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources. The product is based on Eden's plant-derived chemistry, registered in the EU, US and elsewhere, and formulated using Eden's Sustaine® microencapsulation system.

Eden's Sustaine^® encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.

For more information about Eden, please visit:  www.edenresearch.com.

Follow Eden on LinkedIn, Twitter and YouTube. 

 

END